| Monash home | About Monash | Faculties | Campuses | Contact Monash |
| Staff directory | A-Z index | Site map |
|
|
Did you know?11 February 2009
This year marks 10 years since the anti-flu drug Relenza was made available in Australia. Relenza was designed and synthesised by Professor Mark von Itzstein and his team from Monash University's Faculty of Pharmacy and Pharmaceutical Sciences (formally Victorian College of Pharmacy). Human influenza can affect up to 500 million people each year and in high-risk groups, complications can be fatal. Relenza works by inhibiting the life cycle of the flu virus by blocking the viral enzyme that allows it to multiply. For more information visit the Faculty of Pharmacy and Pharmaceutical Sciences website. |